Evidence map›Paper›PMID 29259663›Full record

ArticleBeilstein journal of organic chemistry2017

Sergey L Deev, Alexander S Paramonov, Tatyana S Shestakova, Igor A Khalymbadzha, Oleg N Chupakhin, Julia O Subbotina, Oleg S Eltsov, Pavel A Slepukhin, Vladimir L Rusinov, Alexander S Arseniev and 1 more

Abstract read
In one paragraph

Article in Beilstein journal of organic chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. RSC advances · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sergey L DeevUral Federal University, 19 Mira Street, 620002 Yekaterinburg, Russia.
Alexander S ParamonovShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 16/10 Miklukho-Maklaya Street, 117997 Moscow, Russia.
Tatyana S ShestakovaUral Federal University, 19 Mira Street, 620002 Yekaterinburg, Russia.
Igor A KhalymbadzhaUral Federal University, 19 Mira Street, 620002 Yekaterinburg, Russia.
Oleg N ChupakhinUral Federal University, 19 Mira Street, 620002 Yekaterinburg, Russia.
Julia O SubbotinaUral Federal University, 19 Mira Street, 620002 Yekaterinburg, Russia.
Oleg S EltsovUral Federal University, 19 Mira Street, 620002 Yekaterinburg, Russia.
Pavel A SlepukhinUral Federal University, 19 Mira Street, 620002 Yekaterinburg, Russia.
Vladimir L RusinovUral Federal University, 19 Mira Street, 620002 Yekaterinburg, Russia.
Alexander S ArsenievShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 16/10 Miklukho-Maklaya Street, 117997 Moscow, Russia.
Zakhar O ShenkarevShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 16/10 Miklukho-Maklaya Street, 117997 Moscow, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Determining the accurate chemical structures of synthesized compounds is essential for biomedical studies and computer-assisted drug design. The unequivocal determination of N-adamantylation or N-arylation site(s) in nitrogen-rich heterocycles, characterized by a low density of hydrogen atoms, using NMR methods at natural isotopic abundance is difficult. In these compounds, the heterocyclic moiety is covalently attached to the carbon atom of the substituent group that has no bound hydrogen atoms, and the connection between the two moieties of the compound cannot always be established via conventional

Indexed as

1,2,4-triazolo[1,5-a]pyrimidines15N-labelledadamantylationazolo-1,2,4-triazinesJ-couplingNMR spectra

Identifiers

PMID29259663
PMCPMC5727827

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.